Anne Nagengast Johnson, Chief Financial Officer at ATAI Life Sciences N.V. (ATAI), sold 33,545 shares at $1.35 ($45K) on 2025-03-21, disclosed to the SEC on 2025-03-24.
Open-market sale of $45k ATAI by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.